Peroxide-Simulating and GSH-Depleting Nanozyme for Enhanced Chemodynamic/Photodynamic Therapy via Induction of Multisource ROS.
Gang LiuMingyu LiuXiujing LiXiaorong YeKaiming CaoYang-Zhong LiuYue YuPublished in: ACS applied materials & interfaces (2023)
Reactive oxygen species (ROS) generation, using photodynamic therapy (PDT) and chemodynamic therapy (CDT), is a promising strategy for cancer treatment. However, the production of ROS in tumor cells is often limited by hypoxia, insufficient substrates, and high level of ROS scavengers in a tumor microenvironment, which seriously affects the efficacy of ROS-related tumor therapies. Herein, we report a lipid-supported manganese oxide nanozyme, MLP@DHA&Ce6, by decorating a MnO 2 nano-shell on the liposome loaded with dihydroartemisinin (DHA) and photosensitizer Ce6 for generating multisource ROS to enhance cancer therapy. MLP@DHA&Ce6 can be accumulated in tumors and can release active components, Mn 2+ ions, and O 2 . The conjugate generates ROS via nanozyme-catalyzed CDT using DHA as a substrate, PDT through Ce6, and the Fenton reaction catalyzed by Mn 2+ ions. The production of O 2 from MnO 2 enhanced Ce6-mediated PDT under near-infrared light irradiation. Meanwhile, MLP@DHA&Ce6 showed prominent glutathione depletion, which allowed ROS to retain high activity in tumor cells. In addition, the release of Mn 2+ ions and DHA in tumor cells induced ferroptosis. This multisource ROS generation and ferroptosis effect of MLP@DHA&Ce6 led to enhanced therapeutic effects in vivo.
Keyphrases
- reactive oxygen species
- photodynamic therapy
- cell death
- dna damage
- fatty acid
- cancer therapy
- energy transfer
- room temperature
- fluorescence imaging
- drug delivery
- quantum dots
- oxidative stress
- radiation therapy
- nitric oxide
- stem cells
- wastewater treatment
- mesenchymal stem cells
- hydrogen peroxide
- high glucose
- smoking cessation